Effects of phosphorothioated neuropeptide Y Y1-receptor antisense oligodeoxynucleotide in conscious rats and in human vessels

British Journal of Pharmacology

Volumn 118, Issue 1, 1996, Pages 131-136

  Sun, Xiang Ying ^a   Zhao, Xiao He ^a   Erlinge, David ^b   Edvinsson, Lars ^b   Fallgren, Bo ^d   Wahlestedt, Claes ^c   Hedner, Thomas ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c WEILL CORNELL MEDICAL CENTER   (United States)

^d Perstorp Pharma ^*  (Sweden)

Author keywords

Antisense oligodeoxynucleotide; Conscious rat; Human artery; Long term infusion; Phosphorothioate (metabolically stabilized)

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; GLUCOSE; MESSENGER RNA; NEUROPEPTIDE Y; NEUROPEPTIDE Y1 RECEPTOR; PHOSPHOROTHIOIC ACID DERIVATIVE; SODIUM CHLORIDE;

AMBULATORY MONITORING; ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL; CARDIOVASCULAR FUNCTION; CONTINUOUS INFUSION; CONTROLLED STUDY; DOSE RESPONSE; HEMODYNAMICS; HUMAN; HUMAN TISSUE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; RESISTANCE BLOOD VESSEL; VASOMOTOR REFLEX;

EID: 0029876304     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15375.x     Document Type: Article

References (17)

1. ADNER, M., ERLINGE, D., SALFORD, L.G., YEE, F., WAHLESTEDT C & EDVINSSON, L. (1994). Human endothelin ET-A receptor antisense oligodeoxynucleotides inhibit endothelin-1 evoked vasoconstriction. Eur. J. Pharmacol., 261, 281-284.
2. BALASUBRAMANIAM, A., SHERIFF, S., REGEL, D.F. & FISCHER, J.E. (1990). Characterization of neuropeptide Y binding sites in rat cardiac ventricular membranes. Peptides, 11, 545-550.
3. 3H] proprionyl-neuropeptide Y (NPY) binding in rabbit aortic membranes: comparison with binding in rat brain and biological responses in rat vas deferens. Biochem. Biophys. Res. Commun., 151, 1213-1219.
4. 1 receptor antisense olideoxynucleotide specifically inhibits neuropeptide Y-evoked vasoconstriction. Eur. J. Pharmacol., 240, 77-80.
5. FISHER, T.L., TERHORST, T, CAO, X. & WAGNER, R.W. (1993). Intracellular disposition and metabolism of fluorescently-labeled unmodified and modified oligonucleotides microinjected into mammalian cells. Nucleic Acid Res., 21, 3857-3865.
6. LINTON-DAHLÖF, P. (1989). Modulatory interactions of neuropeptide Y (NPY) on sympathetic neurotransmission. Acta Physiol. Scand., 137, (suppl 586), 1-85.
7. LUNDBERG, J.M., FRIED, G., PERNOW, J., THERODORSSONNORHEIM, E. & ÄNGÅRD, A. (1986). NPY - a mediator of resperine-resistant, non-adrenergic vasoconstriction in cat spleen after preganglionic denvervation? Acta Physiol. Scand., 126, 471-473.
8. LUNDBERG, J.M., HEMSEN, A., LARSSON, O., RUDEHILL, A., SARIA, A. & FREDHOLM, B. (1988). Neuropeptide Y receptor in pig spleen: Binding characteristics, reduction of cyclic AMP formation and calcium antagonist inhibition of vasoconstriction. Eur. J. Pharmacol., 145, 21-29.
9. LUNDBERG, J.M., TERENIUS, L., HÖKFELT, L., HÖKFELT, T. & GOLDSTEIN, M. (1983). High levels of neuropeptide Y (NPY) in peripheral noradrenergic neurons in various mammals including man. Neurosci. Lett., 42, 167-172.
10. SHIGERI, Y., MIHARA, S.I. & FUJIMOTO, M. (1991). Neuropeptide Y receptor in vascular smooth muscle. J. Neurochem., 56, 852-859.
11. TATEMOTO, K., CARLQUIST, M. & MUTT, V. (1982). Neuropeptide Y - a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature, 296, 659-660.
12. WAEBER, B., AUBERT, J.F., CORDER, R. & EVÉQUOZ, D. (1988). Cardiovascular effects of neuropeptide Y. Am. J. Hypertens., 1, 193-199.
13. WAHLESTEDT, C. (1994). Antisense oligonucleotide strategies in neuropharmacology. Trends Pharmacol. Sci., 15, 42-46.
14. 2-receptors. In Neuronal Messengers in Vascular Function. ed. Nobin, A., Owman, C. & Arneklo-Nobin, B. pp. 231-241. Amsterdam: Elsevier Science Publishers.
15. 1 receptor by antisense oligodeoxynucleotide. Science, 259, 528-531.
16. WAHLESTEDT, C., YANAIHARA, N. & HÅKANSON, R. (1986). Evidence for different pre- and postjunctional receptors for neuropeptide Y and related peptides. Regul. Pept., 13, 307-318.
17. ZUKOWSKA-GROJEC, Z., MARKS, E.S. & HAASS, M (1987). Neuropeptide Y is a potent vasoconstrictor and a cardiodepressant in rats. Am. J. Physiol., 253, H12334-H1239.